Service
Skin microbiome testing with C. acnes ribotyping and personalized skincare advice using Oxford Nanopore sequencing.
CEO
Nomads, UAB
Vilnius, Lithuania
CEO of Nomads, specializing in skin microbiome, recombinant bacteriocins, and plant expression systems. Bridging science and innovation in skincare.
Dr. Aušra Ražanskienė is President of Nomads UAB, a Lithuanian biotechnology company developing microbiome-based innovations and precision antibacterial proteins. With over 25 years of experience in molecular biology, recombinant protein expression, and biotechnology R&D, she has led numerous national and international research projects and has authored over 25 peer-reviewed publications and multiple patent applications. Her current work focuses on bacteriophage-derived antibacterial proteins, skin microbiome diagnostics, and the development of innovative microbiome-modulating products for dermatology and healthcare.
Service
Skin microbiome testing with C. acnes ribotyping and personalized skincare advice using Oxford Nanopore sequencing.
Service
Recombinant protein expression
Expertise in recombinant protein expression in plants, yeast, and bacteria, including strategies for handling toxic proteins.
Product
Antibacterial protein specificaly targetting Cutibacterium acnes
Phage-derived protein targets C. acnes with nanomolar MICs; stable 2+ years. Seeking partners to develop acne skin treatment.